Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... of Sciences of the United States of America report. "Human embryonic stem cells (hESCs) were differentiated to cardiomyocytes by using activin A and BMP-4 and ... comprising only cardiomyocytes. Implantation of these patches resulted in 10-fold larger cell grafts compared with patches composed only of cardiomyocytes. Moreover, the preformed ... effects of scaffold materials, necrosis at the tissue core, and poor survival after transplantation due to ischemic injury. Here, we report the development of scaffold-free prevascularized ...
2009 NOV 23 ... Transplantation, Hematologic Disease, Hematology, Hematopoietic, Nosocomial Infection, StemCell Research. This article was prepared by Hematology Week editors from ...
2009 NOV 23 ... Genetix Pharmaceuticals, a leader in gene therapy of somatic stem cells, announced the company's clinical program to treat Adrenoleukodystrophy (ALD). ... Genomics, Marketing and Licensing Agreements, Pharmaceuticals, Regulatory Actions, Stem Cell Research, Treatment, Genetix Pharmaceuticals. This article was prepared by ... with this disease. ALD is currently treated with allogeneic bone marrow transplantation when there is an appropriate donor. Even so, the graft sometimes does not take and there ...
2009 NOV 23 ... data showing that oligodendrocyte progenitor cells (OPCs) derived from human embryonic stem cells (hESCs), when transplanted into a rodent model of cervical spinal cord injury, ... and colleagues at the Reeve-Irvine Research Center and the Sue & Bill Gross Stem Cell Research Center at the University of California at Irvine. The paper was published ... president and chief executive officer. "These preclinical studies demonstrate that transplantation of hESC-derived OPCs resulted in sparing of spinal cord tissue in the cervical lesion ...
2009 NOV 23 ... International StemCell Corporation (OTCBB:ISCO), www.internationalstemcell.com announced that it had made ... Novo Nordisk and SangStat/Genzyme, global leaders in biological therapies, diabetes, transplantation and other chronic diseases. As ISCO's President, Mr. Lundstrom will focus ...
2009 NOV 23 ... 2009;78(4):232-40). For additional information, contact V.S. Parekh, Stem Cells and Diabetes Section, Laboratory #12, National Center for Cell Science, ... ability to differentiate into insulin-producing cells. We observe that after 9 weeks of transplantation, approximately 25% grafts exhibit human insulin-producing (16% immunopositive) cells. ...
2009 NOV 23 ... on the use of the homeopathic agent Traumeel S=AE in children with mucositis undergoing stem cell transplantation (SCT). Investigated by the Children's Oncology Group, the multi-center randomized ...
2009 NOV 23 ... A report, 'Aspirin induces apoptosis in mesenchymal stem cells requiring Wnt/beta-catenin pathway,' is newly published data in Cell ... conditions; therefore, it should be used with caution when considering regenerative MSC transplantation in patients with concomitant chronic inflammatory diseases such as arthritis." ...
2009 NOV 23 ... without bFGF." "The ratio of hDPCs expressing STRO-1 as a marker of stemcell populations increased approximately eightfold in the presence of bFGF as opposed to ... in vitro differentiation was confirmed at both the protein and gene expression levels. Transplantation of hDPCs-expanded ex vivo in the presence of bFGF into immunocompromised mice-revealed ...
2009 NOV 23 ... or refractory to first-line therapy achieve a durable response after peripheral blood stem cell transplantation (PBSCT)," scientists in Rome, Italy report. "Patients relapsing after a ...
2009 NOV 23 ... enrolled in a Phase III trial of maintenance therapy +/-thalidomide after autologous stem cell transplantation. TCR Vbeta repertoire analysis identified T cell expansions in 48% of patients ...
2009 NOV 23 ... cord blood are presented in the report 'Late infectious complications after cord blood stem cell transplantation.' According to a study from the United States, "The slower engraftment kinetics and ...
2009 NOV 23 ... aspergillosis is a significant cause of morbidity and mortality in patients after stem cell transplantation, in solid organ transplant recipients, and in patients with hematological malignancies. ...
2009 NOV 23 ... including the appropriate sequence of chemotherapy, combined modality therapy, and stem cell transplantation is not well-established," wrote H. Kohrt and colleagues, Stanford University, ...
2009 NOV 28 ... Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal ... by the body's inability to produce specific lysosomal enzymes. Lysosomes, part of a cell's internal machinery, help the body's cells break down large molecules and recycle ... experiments to reprogram the stem cells to produce IDUA. They then performed bone marrow transplantation on the MPS I mice with the reprogrammed cells. The developing red blood cells in these ...
Subject: Cincinnati Children's Hospital Medical Center
2009 NOV 23 ... (CR) could be shown only after introduction of high-dose therapy plus autologous stem cell transplantation (ASCT). In the context of ASCT, achieving CR (negative immunofixation and normal bone ...
2009 NOV 27 ... immune rejection is to introduce autologous cells. Ependymal cells, induced pluripotent stem cells, and olfactory neuroepithelial cells have been recognized as promising sources, ... recognized as promising sources, which will spur ongoing efforts to evaluate these new cell sources for cell replacement therapy," wrote D.G. Wei and colleagues, University of ... and differentiation of endogenous cells at the damaged site and the autologous transplantation Recent findings Self-repair refers to a favorable structural and functional outcome of ...
